Is colectomy for fulminant Clostridium difficile colitis life saving? A systematic review

Area of Science:

• Gastroenterology
• Surgical Oncology
• Infectious Diseases

Background:

• Fulminant Clostridium difficile colitis (FCDC) represents a severe, life-threatening condition.
• Optimal treatment strategies for FCDC, particularly the role of colectomy versus continued medical therapy, remain debated in moribund patient populations.

Purpose of the Study:

• To determine if colectomy improves survival rates in patients diagnosed with FCDC compared to those receiving continued medical therapy.
• To evaluate the therapeutic role of emergent colectomy in managing severe C. difficile colitis.

Main Methods:

• A systematic review and meta-analysis were conducted on studies published between 1994 and 2010.
• Data on mortality rates from six studies involving 510 patients with FCDC were extracted and analyzed.
• The Mantel-Haenszel method with fixed-effects modeling was used to calculate the pooled odds ratio for mortality.

Main Results:

• The pooled adjusted odds ratio for mortality comparing surgery to medical therapy was 0.70 (95% CI: 0.49-0.99), indicating a survival advantage for surgical intervention.
• Analysis of six studies identified 510 patients with FCDC, with the meta-analysis suggesting a statistically significant benefit of colectomy.

Conclusions:

• Emergent colectomy for FCDC is associated with improved survival outcomes when contrasted with antibiotic treatment alone.
• Despite potential selection bias in surgical candidates, colectomy demonstrates a significant therapeutic role in managing severe cases of C. difficile colitis.